Analystreport

Cellular Biomedicine Group Inc (NASDAQ: CBMG) was given a new $38.00 price target on by analysts at B. Riley. They now have a "buy" rating on the stock.

CELLULAR BIOMEDICINE GROUP INC  (CBMG) 
Last cellular biomedicine group inc earnings: 11/6 04:25 pm Check Earnings Report
US:NASDAQ Investor Relations: cellbiomedgroup.com/investor-relations